Evolus Inc Stock Alpha and Beta Analysis
| EOLS Stock | USD 13.97 0.24 1.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Evolus Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Evolus over a specified time horizon. Remember, high Evolus' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Evolus' market risk premium analysis include:
Beta 0.92 | Alpha (0.21) | Risk 5.07 | Sharpe Ratio (0.03) | Expected Return (0.15) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Evolus |
Evolus Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Evolus market risk premium is the additional return an investor will receive from holding Evolus long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Evolus. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Evolus' performance over market.| α | -0.21 | β | 0.92 |
Evolus expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Evolus' Buy-and-hold return. Our buy-and-hold chart shows how Evolus performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Evolus Market Price Analysis
Market price analysis indicators help investors to evaluate how Evolus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evolus shares will generate the highest return on investment. By understating and applying Evolus stock market price indicators, traders can identify Evolus position entry and exit signals to maximize returns.
Evolus Return and Market Media
The median price of Evolus for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 is 12.6 with a coefficient of variation of 15.48. The daily time series for the period is distributed with a sample standard deviation of 1.98, arithmetic mean of 12.78, and mean deviation of 1.6. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Evolus Inc Shares Up 3.51 percent on Nov 27 | 11/27/2024 |
2 | TANG CAPITAL MANAGEMENT LLC Increases Stake in Cybin Inc | 12/04/2024 |
3 | Disposition of 175940 shares by David Moatazedi of Evolus at 7.28 subject to Rule 16b-3 | 12/10/2024 |
4 | Charles Schwab Investment Management Inc. Raises Stake in Evolus, Inc. - MarketBeat | 12/12/2024 |
5 | Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 12/13/2024 |
6 | Acquisition by Parschauer Karah Herdman of 11789 shares of Evolus at 10.25 subject to Rule 16b-3 | 12/20/2024 |
7 | Disposition of 10502 shares by David Moatazedi of Evolus at 10.8519 subject to Rule 16b-3 | 12/23/2024 |
8 | Evolus Inc Shares Gap Down to 10.33 on Jan 8 | 01/08/2025 |
9 | Evolus Surges 28.3 percent Is This an Indication of Further Gains - Yahoo Finance | 01/22/2025 |
10 | Disposition of 2252 shares by Avelar Rui of Evolus at 10.8519 subject to Rule 16b-3 | 01/29/2025 |
11 | Acquisition by Gill David N of 8293 shares of Evolus subject to Rule 16b-3 | 01/31/2025 |
About Evolus Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Evolus or other stocks. Alpha measures the amount that position in Evolus Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 6.25 | 14.41 | 12.97 | 13.62 | Days Of Inventory On Hand | 123.12 | 65.21 | 74.99 | 123.6 |
Evolus Upcoming Company Events
As portrayed in its financial statements, the presentation of Evolus' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evolus' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Evolus' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Evolus. Please utilize our Beneish M Score to check the likelihood of Evolus' management manipulating its earnings.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Evolus
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.